Akero Therapeutics Inc

AKROStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$54.00

Today

-1.2%

YTD

-1.1%

About

Akero Therapeutics Inc, based in the US, is a clinical-stage biotechnology firm committed to the advancement of transformative medicines for patients with non-alcoholic steatohepatitis (NASH) and other severe liver diseases. Akero Therapeutics Inc is mainly recognised for its flagship product, Efruxifermin (EFX), which is designed for NASH treatment. Being an independent entity, Akero stands out in its commitment to medical innovation, especially in the field of NASH, a serious concern with largely unmet needs. Stay up to date on the share price of AKRO by adding it to your eToro watchlist.

Price chart

Closing price history for AKRO (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-14.58

P/S (TTM)0.00

P/B (TTM)4.57

Market cap$4.50B

Cap tierMid-cap

Industry avg P/E-7.42

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-34.53%

ROA-32.12%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$3.75

Free cash flow$-250.17M

Total debt$1.16M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.95

Employees63

Next earnings27 Feb '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.